MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 14 filers reported holding MONOPAR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $496 | -85.5% | 800 | -80.0% | 0.00% | – |
| Q2 2023 | $3,420 | -38.5% | 4,000 | 0.0% | 0.00% | – |
| Q1 2023 | $5,560 | -41.4% | 4,000 | 0.0% | 0.00% | – |
| Q4 2022 | $9,480 | +58.0% | 4,000 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -33.3% | 4,000 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -10.0% | 4,000 | -0.1% | 0.00% | – |
| Q1 2022 | $10,000 | -23.1% | 4,003 | +0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -31.6% | 4,001 | +0.0% | 0.00% | – |
| Q3 2021 | $19,000 | -20.8% | 4,000 | 0.0% | 0.00% | – |
| Q2 2021 | $24,000 | +20.0% | 4,000 | +25.0% | 0.00% | – |
| Q1 2021 | $20,000 | 0.0% | 3,200 | 0.0% | 0.00% | – |
| Q4 2020 | $20,000 | +17.6% | 3,200 | 0.0% | 0.00% | – |
| Q3 2020 | $17,000 | -29.2% | 3,200 | 0.0% | 0.00% | – |
| Q2 2020 | $24,000 | +4.3% | 3,200 | 0.0% | 0.00% | – |
| Q1 2020 | $23,000 | -87.0% | 3,200 | -69.9% | 0.00% | – |
| Q4 2019 | $177,000 | – | 10,632 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Windsor Advisory Group, LLC | 89,974 | $55,775 | 0.13% |
| Rappaport Reiches Capital Management, LLC | 10,695 | $6,630 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,727 | $2,311 | 0.00% |
| JPMORGAN CHASE & CO | 4 | $2 | 0.00% |
| VANGUARD GROUP INC | 87,596 | $54,301 | 0.00% |
| UBS Group AG | 72 | $45 | 0.00% |
| WELLS FARGO & COMPANY/MN | 33 | $20 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 41,199 | $23,483 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 19,008 | $10,835 | 0.00% |